Zi Xiang Lim

Dr. Zi Xiang Lim

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
BGBibek Gyanwali
Bibek Gyanwali
ZLZi Xiang Lim
Zi Xiang Lim
JSJanjira Soh
Janjira Soh
CLClarissa Lim
Clarissa Lim
SGShou Ping Guan
Shou Ping Guan
BKBrian K. Kennedy
Brian K. Kennedy

23 May 2023 in GeroScience
Verified
Journal Article
Open access
PDF file
ESElena Sandalova
Elena Sandalova
Jorming GohJorming Goh
Jorming Goh
ZLZi Xiang Lim
Zi Xiang Lim
ZLZhi Meng Lim
Zhi Meng Lim
DBDiogo Barardo
Diogo Barardo
Andrea Britta MaierAndrea Britta Maier
Andrea Britta Maier
Targeting molecular processes of aging will enable people to live healthier and longer lives by preventing age-related diseases. Geroprotectors are compounds with the potential to increase healthspan and lifespan. Even though many of them have been tested in animal models, the translation to humans is limited. Alpha-Ketoglutarate (AKG) has been studied widely in model animals, but there are few studies testing its geroprotective properties in humans. ABLE is a double blinded placebo-controlled randomized trial (RCT) of 1 g sustained release Ca-AKG versus placebo for 6 months of intervention and 3 months follow up including 120 40–60-year-old healthy individuals with a higher DNA methylation age compared to their chronological age. The primary outcome is the decrease in DNA methylation age from baseline to the end of the intervention. A total of 120 participants will be randomized to receive either sustained release Ca-AKG or placebo. Secondary outcomes include changes in the inflammatory and metabolic parameters in blood, handgrip strength and leg extension strength, arterial stiffness, skin autofluorescence, and aerobic capacity from baseline to 3 months, 6 months, and 9 months. This study will recruit middle-aged participants with an older DNA methylation age compared to their chronological age, and test whether supplementation with Ca-AKG can reduce DNA methylation age. This study is unique in its inclusion of biologically older participants.

18 October 2023 in GeroScience
Verified
Journal Article
Open access
PDF file
JSJanjira Soh
Janjira Soh
SRShivaanishaa Raventhiran
Shivaanishaa Raventhiran
JLJasinda H. Lee
Jasinda H. Lee
ZLZi Xiang Lim
Zi Xiang Lim
JGJorming Goh
Jorming Goh
Andrea Britta MaierAndrea Britta Maier
Andrea Britta Maier
Functional decline of physiological systems during ageing leads to age-related diseases. Dietary glycine increases healthy lifespan in model organisms and might decrease inflammation in humans, suggesting its geroprotective potential. This review summarises the evidence of glycine administration on the characteristics of eleven physiological systems in adult humans. Databases were searched using key search terms: ‘glycine’, ‘adult’, ‘supplementation’/ ‘administration’/ ‘ingestion’/ ‘treatment’. Glycine was administered to healthy and diseased populations (18 and 34 studies) for up to 14 days and 4 months, respectively. The nervous system demonstrated the most positive effects, including improved psychiatric symptoms from longer-term glycine administration in psychiatric populations. While longer-term glycine administration improved sleep in healthy populations, these studies had small sample sizes with a high risk of bias. Larger and long-term studies with more robust study designs in healthy populations to examine the effects of glycine administration on preventing, delaying or reversing the ageing process are warranted.

2 January 2020 in Free Radical Research
Verified
Journal Article
Closed access
ZLZi Xiang Lim
Zi Xiang Lim
MDMarisa N. Duong
Marisa N. Duong
ABAmber E. Boyatzis
Amber E. Boyatzis
EGEmily Golden
Emily Golden
AVAlice Vrielink
Alice Vrielink
PAPeter G. Arthur
Peter G. Arthur
Introduction: In order to better understand the physiological and pathophysiological roles of reactive oxygen species (ROS), multiple blood and urine biomarkers of oxidative stress have been developed. The single free thiol (Cys34) in plasma albumin is a useful biomarker of oxidative stress because thiol groups are particularly sensitive to oxidation by ROS. The primary aim of this study was to develop a gel electrophoresis-based method (mPEG assay) that would be more widely accessible than existing chromatography techniques to assay the oxidation state of albumin Cys34. Method: Blood samples were collected into a solution containing polyethylene glycol maleimide (malpeg). Plasma samples were divided into two aliquots, with a reducing agent added to one aliquot. Albumin bound to malpeg was separated from albumin by gel electrophoresis. The proportion of albumin in reduced form (–SH), disulphide form (–SSX) and irreversibly oxidised form (–SO2, –SO3) could then be calculated. Results: Data for the mPEG assay was comparable to data from chromatographic and mass spectrometric assays. The mPEG assay was more sensitive than the albumin carbonyl assay for the detection of changes in albumin oxidation level in response to exposure to hydrogen peroxide or hypochlorous acid. This assay could also be performed on small blood samples (less than 10 µL) from fingerprick, thus facilitating longitudinal tracking of changes in albumin Cys34 oxidation level. Conclusion: The mPEG assay is a user-friendly, highly sensitive, specific, cost-effective gel electrophoresis-based method for the assay of the oxidations state of albumin Cys34 as a biomarker of oxidative stress.

20 June 2022 in European Review of Aging and Physical Activity
Verified
Journal Article
Open access
PDF file
ZLZi Xiang Lim
Zi Xiang Lim
Jorming GohJorming Goh
Jorming Goh
Background: Aging leads to a number of structural and physiological deficits such as loss of muscle mass and strength. Strength training at ~ 70% of 1 repetition max (RM) is recommended to prevent age-related loss of muscle mass and strength. However, most older adults may not be able to perform 70% of 1RM or higher intensity. An alternative exercise training program combining low intensity resistance exercise with blood flow restriction (BFR) can result in similar acute and chronic benefits to skeletal muscles in older adults. Main body and short conclusion: The potential mechanisms involved are discussed, and include reactive hyperaemia, metabolic stress, and hypoxia. Key issues and safety with the use of BFR in older adults, especially those with chronic conditions are also discussed. Although there has been no reported evidence to suggest that BFR elevates the risk of clinical complications any more than high intensity exercise, it is recommended for individuals to be medically cleared of any cardiovascular risks, prior to engaging in BFR exercise.

22 January 2018 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
GKGeorgina L. Kent
Georgina L. Kent
BDBrian Dawson
Brian Dawson
GCGregory Ronald Cox
Gregory Ronald Cox
CAChris R. Abbiss
Chris R. Abbiss
KSKurt J. Smith
Kurt J. Smith
PPPeter Peeling
Peter Peeling